Sort
16,179 grants matching “malaria”
NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING
$797,049Ram Samudrala · University Of Washington · DP1 · FY2013 · LM
Human Genetic determinants of HBV recovery
$796,842David L Thomas · Johns Hopkins University · R01 · FY2022 · AI
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
$796,698Charles W. Flexner · Johns Hopkins University · R24 · FY2024 · AI
Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of mice
$796,541Erol Fikrig · Yale University · R01 · FY2024 · AI
Translational studies of hookworm infection in Ghana
$796,540Michael Cappello · Yale University · R01 · FY2022 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$796,534Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2011 · AI
Thymidylate synthase inhibitors for malaria
$796,392University Of Washington · P01 · FY2005 · AI
Novel Antimalarials from Fungi
$795,805Debopam Chakrabarti · University Of Central Florida · R01 · FY2020 · AI
Epidemiology of Malaria in Malawi: Human Hosts and Parasites in Three Districts
$795,632Miriam K Laufer · Michigan State University · U19 · FY2014 · AI
Defining functional humoral correlates of immunity to guide vaccine design
$795,292Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2023 · AI
Redefining thermal suitability for urban malaria transmission in the context of humidity
$795,037Courtney Murdock · Cornell University · R01 · FY2020 · AI
Artemisinin Resistance in Africa: its emergence and evolution in Rwanda
$794,882Jeffrey A. Bailey · Brown University · R01 · FY2021 · AI
Genome-wide CRISPR-Cas9 screens in insect cells to characterize insecticidal toxins
$794,860Min Dong · Boston Children'S Hospital · R01 · FY2023 · AI
Genome-wide CRISPR-Cas9 screens in insect cells to characterize insecticidal toxins
$794,860Min Dong · Boston Children'S Hospital · R01 · FY2024 · AI
Protein Sequencing by Tandem Mass Spectrometry
$794,624University Of Virginia Charlottesville · R01 · FY2005 · GM
Engineering the genetics of wild mosquito populations to fight infectious disease
$794,475Bruce A Hay · California Institute Of Technology · DP1 · FY2012 · GM
Engineering the genetics of wild mosquito populations to fight infectious disease
$794,475Bruce A Hay · California Institute Of Technology · DP1 · FY2011 · OD
Adjuvants for Skin Immunization: Discovery and Mechanisms
$794,321Ioanna Skountzou · Emory University · R01 · FY2014 · AI
Optimization of pyrimidinyl prodrugs (PYPs) for malaria chemotherapy
$794,004Pradipsinh K. Rathod · University Of Washington · R56 · FY2009 · AI
Optimizing strategies for malaria surveillance and measuring the impact of contro
$793,881Moses Robert Kamya · University Of California, San Francisco · U19 · FY2011 · AI
Development of an oral liver-targeted prime-and-trap malaria vaccine
$793,041Sean C Murphy · University Of Washington · U01 · FY2025 · AI
AFRICAN MALARIA VECTORS
$792,993University Of Miami School Of Medicine · U19 · FY2003 · AI
Safe Pregnancy by Infectious Disease Control in Kinshasa
$792,697University Of North Carolina Chapel Hill · U01 · FY2004 · HD
Adjuvants for Skin Immunization: Discovery and Mechanisms
$792,636Ioanna Skountzou · Emory University · R01 · FY2015 · AI
Parasite and host cell factors involved in the formation and persistence of Plasmodium vivax hypnozoites
$792,319Stefan H.i. Kappe · Seattle Children'S Hospital · R01 · FY2024 · AI